Library Subscription: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Published 6 issues per year

ISSN Print: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Capture of Stealth Nanoparticles by the Body’s Defences

Volume 18, Issue 6, 2001, 24 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i6.30
Get accessGet access

ABSTRACT

This article highlights and discusses our experience in the design, handling, and biological evaluation of long-circulating nanoparticles based on polyoxypropylene/polyoxyethylene copolymer nonionic surfactants. A frequently observed but ignored phenomenon following intravenous injection of such polymer-modified long-circulating colloidal systems is their eventual recognition and clearance by macrophages of the reticuloendothelial system. The pharmacokinetics as well as the tissue distribution of such so-called “stealth” nanoparticles are also altered after repeated intravenous injection in a time-dependent manner. An understanding of immunological and pathological factors that control the pharmacokinetic and biological behavior of long-circulating particles after single or repeated administration is therefore crucial for the design of a system with an optimal diagnostic and/or therapeutic performance. Therefore, we have also examined and discussed the concept of macrophage recognition of a “stealth-like nature” and factors that initiate this cascade. A critical discussion of the future of this interesting area of nano-biotechnology/engineering is also provided.

CITED BY
  1. Vonarbourg Arnaud, Saulnier Patrick, Passirani Catherine, Benoit Jean-Pierre, Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface, ELECTROPHORESIS, 26, 11, 2005. Crossref

  2. Haghniaz Reihaneh, Bhayani Kavita R., Umrani Rinku D., Paknikar Kishore M., Dextran stabilized lanthanum strontium manganese oxide nanoparticles for magnetic resonance imaging, RSC Advances, 3, 40, 2013. Crossref

  3. Ernsting Mark J., Murakami Mami, Roy Aniruddha, Li Shyh-Dar, Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles, Journal of Controlled Release, 172, 3, 2013. Crossref

  4. Borm Paul J.A., Schins Roel P.F., Albrecht Catrin, Inhaled particles and lung cancer, part B: Paradigms and risk assessment, International Journal of Cancer, 110, 1, 2004. Crossref

  5. Varma Abhay K., Das Arabinda, Wallace Gerald, Barry John, Vertegel Alexey A., Ray Swapan K., Banik Naren L., Spinal Cord Injury: A Review of Current Therapy, Future Treatments, and Basic Science Frontiers, Neurochemical Research, 38, 5, 2013. Crossref

  6. Parveen Suphiya, Sahoo Sanjeeb K., Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery, European Journal of Pharmacology, 670, 2-3, 2011. Crossref

  7. Vonarbourg A., Passirani C., Saulnier P., Simard P., Leroux J.C., Benoit J.P., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, 78A, 3, 2006. Crossref

  8. Yang Xi, Cao Dan, Wang Ning, Sun Lu, Li Ling, Nie Shihong, Wu Qinjie, Liu Xinyu, Yi Cheng, Gong Changyang, In Vitro and In Vivo Safety Evaluation of Biodegradable Self-Assembled Monomethyl Poly (Ethylene Glycol)–Poly(ε-Caprolactone)–Poly (Trimethylene Carbonate) Micelles, Journal of Pharmaceutical Sciences, 103, 1, 2014. Crossref

  9. Wang Yuhua, Huang Leaf, Lipid Nanoparticles for the Delivery of Nucleic Acids, in Pharmaceutical Sciences Encyclopedia, 2013. Crossref

  10. Labhasetwar Vinod, Sahoo Sanjeeb, Nanoparticle Interface, in Nanoparticle Technology for Drug Delivery, 159, 2006. Crossref

  11. Schins Roel, Borm Paul, Toxicological Characterization of Engineered Nanoparticles, in Nanoparticle Technology for Drug Delivery, 159, 2006. Crossref

  12. Thasneem Y.M., Rekha M.R., Sajeesh S., Sharma Chandra P., Biomimetic mucin modified PLGA nanoparticles for enhanced blood compatibility, Journal of Colloid and Interface Science, 409, 2013. Crossref

  13. Roh K.-H., Yoshida M., Lahann J., Compartmentalized, multiphasic nanocolloids with potential applications in drug delivery and biomedical imaging, Materialwissenschaft und Werkstofftechnik, 38, 12, 2007. Crossref

  14. Ström Valter, Hultenby Kjell, Grüttner Cordula, Teller Joachim, Xu Bo, Holgersson Jan, A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer, Nanotechnology, 15, 5, 2004. Crossref

  15. Kingsley Jeffrey D., Dou Huanyu, Morehead Justin, Rabinow Barrett, Gendelman Howard E., Destache Christopher J., Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System, Journal of Neuroimmune Pharmacology, 1, 3, 2006. Crossref

  16. Zhao Li, Xu Yong-Hong, Akasaka Tsukasa, Abe Shigeaki, Komatsu Naoki, Watari Fumio, Chen Xiao, Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells, Biomaterials, 35, 20, 2014. Crossref

  17. Al-Hallak M. H. D. Kamal, Azarmi Shirzad, Sun Chris, Lai Patrick, Prenner Elmar J., Roa Wilson H., Löbenberg Raimar, Pulmonary Toxicity of Polysorbate-80-coated Inhalable Nanoparticles; In vitro and In vivo Evaluation, The AAPS Journal, 12, 3, 2010. Crossref

  18. Yacobi Nazanin R., Fazllolahi Farnoosh, Kim Yong Ho, Sipos Arnold, Borok Zea, Kim Kwang-Jin, Crandall Edward D., Nanomaterial interactions with and trafficking across the lung alveolar epithelial barrier: implications for health effects of air-pollution particles, Air Quality, Atmosphere & Health, 4, 1, 2011. Crossref

  19. Sheng Yan, Yuan Yuan, Liu Changsheng, Tao Xinyi, Shan Xiaoqian, Xu Feng, In vitro macrophage uptake and in vivo biodistribution of PLA–PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content, Journal of Materials Science: Materials in Medicine, 20, 9, 2009. Crossref

  20. Dhand Chetna, Prabhakaran Molamma P., Beuerman Roger W., Lakshminarayanan R., Dwivedi Neeraj, Ramakrishna Seeram, Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery, RSC Adv., 4, 62, 2014. Crossref

  21. Ren L, Chow G.M, Synthesis of nir-sensitive Au–Au2S nanocolloids for drug delivery, Materials Science and Engineering: C, 23, 1-2, 2003. Crossref

  22. Santander-Ortega Manuel J., Lozano-López María V., Bastos-González Delfina, Peula-García José M., Ortega-Vinuesa Juan L., Novel core-shell lipid-chitosan and lipid-poloxamer nanocapsules: stability by hydration forces, Colloid and Polymer Science, 288, 2, 2010. Crossref

  23. Yaméogo Josias B.G., Gèze Annabelle, Choisnard Luc, Putaux Jean-Luc, Gansané Adama, Sirima Sodiomon B., Semdé Rasmané, Wouessidjewe Denis, Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers – I: Formulation, lyoavailability and in vitro antimalarial activity assessment, European Journal of Pharmaceutics and Biopharmaceutics, 80, 3, 2012. Crossref

  24. Babu Dhanikula Anand, Mohamed Khalid Nabil, Lee Stephen D., Yeung Rosanna, Risovic Verica, Wasan Kishor M., Leroux Jean-Christophe, Long circulating lipid nanocapsules for drug detoxification, Biomaterials, 28, 6, 2007. Crossref

  25. Patra Chitta Ranjan, Abdel Moneim Soha S., Wang Enfeng, Dutta Shamit, Patra Sujata, Eshed Michal, Mukherjee Priyabrata, Gedanken Aharon, Shah Vijay H., Mukhopadhyay Debabrata, In vivo toxicity studies of europium hydroxide nanorods in mice, Toxicology and Applied Pharmacology, 240, 1, 2009. Crossref

  26. Vonarbourg Arnaud, Passirani Catherine, Saulnier Patrick, Benoit Jean-Pierre, Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, 27, 24, 2006. Crossref

  27. Chambers Elizabeth, Mitragotri Samir, Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes, Journal of Controlled Release, 100, 1, 2004. Crossref

  28. Wenger Yvan, Schneider Randal J., Reddy G. Ramachandra, Kopelman Raoul, Jolliet Olivier, Philbert Martin A., Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat, Toxicology and Applied Pharmacology, 251, 3, 2011. Crossref

  29. Liu Teng, Shi Sixiang, Liang Chao, Shen Sida, Cheng Liang, Wang Chao, Song Xuejiao, Goel Shreya, Barnhart Todd E., Cai Weibo, Liu Zhuang, Iron Oxide Decorated MoS2 Nanosheets with Double PEGylation for Chelator-Free Radiolabeling and Multimodal Imaging Guided Photothermal Therapy, ACS Nano, 9, 1, 2015. Crossref

  30. Nukolova Natalia V., Oberoi Hardeep S., Cohen Samuel M., Kabanov Alexander V., Bronich Tatiana K., Folate-decorated nanogels for targeted therapy of ovarian cancer, Biomaterials, 32, 23, 2011. Crossref

  31. Landsiedel Robert, Fabian Eric, Ma-Hock Lan, Wohlleben Wendel, Wiench Karin, Oesch Franz, van Ravenzwaay Ben, Toxico-/biokinetics of nanomaterials, Archives of Toxicology, 86, 7, 2012. Crossref

  32. Moghimi S.M, Pavey K.D, Hunter A.C, Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908, FEBS Letters, 547, 1-3, 2003. Crossref

  33. Moghimi S.M., Szebeni J., Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties, Progress in Lipid Research, 42, 6, 2003. Crossref

  34. Chen Jiezhong, Gu Wenyi, Yang Lei, Chen Chen, Shao Renfu, Xu Kewei, Xu Zhi Ping, Nanotechnology in the management of cervical cancer, Reviews in Medical Virology, 25, 2015. Crossref

  35. Shan Xiaoqian, Liu Changsheng, Yuan Yuan, Xu Feng, Tao Xinyi, Sheng Yan, Zhou Huanjun, In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer, Colloids and Surfaces B: Biointerfaces, 72, 2, 2009. Crossref

  36. Aggarwal Parag, Hall Jennifer B., McLeland Christopher B., Dobrovolskaia Marina A., McNeil Scott E., Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy, Advanced Drug Delivery Reviews, 61, 6, 2009. Crossref

  37. Petrak Karel, Nanotechnology and site-targeted drug delivery, Journal of Biomaterials Science, Polymer Edition, 17, 11, 2006. Crossref

  38. Lamprecht Alf, Nanomedicines in gastroenterology and hepatology, Nature Reviews Gastroenterology & Hepatology, 12, 4, 2015. Crossref

  39. Hunter A.Christy, Moghimi S.Moein, Synthetic polymers in 21st century therapeutics: the way forward ▾, Drug Discovery Today, 8, 4, 2003. Crossref

  40. Yang Wei, Peters Jay I., Williams Robert O., Inhaled nanoparticles—A current review, International Journal of Pharmaceutics, 356, 1-2, 2008. Crossref

  41. Kah James Chen Yong, Wong Ker Yi, Neoh Koon Gee, Song Jie Han, Fu Jason Wei Ping, Mhaisalkar Subodh, Olivo Malini, Sheppard Colin James Richard, Critical parameters in the pegylation of gold nanoshells for biomedical applications: Anin vitromacrophage study, Journal of Drug Targeting, 17, 3, 2009. Crossref

  42. Hughes Gareth A., Nanostructure-mediated drug delivery, Nanomedicine: Nanotechnology, Biology and Medicine, 1, 1, 2005. Crossref

  43. Moghimi S.Moein, Hunter A.Christy, Dadswell Christopher M, Savay Sandor, Alving Carl R, Szebeni Janos, Causative factors behind poloxamer 188 (Pluronic F68, Flocor™)-induced complement activation in human sera, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1689, 2, 2004. Crossref

  44. Veiseh Omid, Gunn Jonathan W., Zhang Miqin, Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging, Advanced Drug Delivery Reviews, 62, 3, 2010. Crossref

  45. Lamprecht Alf, Saumet Jean-Louis, Roux Jérôme, Benoit Jean-Pierre, Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment, International Journal of Pharmaceutics, 278, 2, 2004. Crossref

  46. Hughes Gareth A., Nanostructure-Mediated Drug Delivery, Disease-a-Month, 51, 6, 2005. Crossref

  47. Moghimi Seyed Moein, Complement Propriety and Conspiracy in Nanomedicine: Perspective and a Hypothesis, Nucleic Acid Therapeutics, 26, 2, 2016. Crossref

  48. Snehalatha Movva, Venugopal Kolachina, Saha Ranendra N., Babbar Anil Kumar, Sharma Rakesh Kumar, Etoposide Loaded PLGA and PCL Nanoparticles II: Biodistribution and Pharmacokinetics after Radiolabeling with Tc-99m, Drug Delivery, 15, 5, 2008. Crossref

  49. Zhao Jun, Li Chun, Micelles: Tumor Imaging and Drug Delivery, in Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 2015. Crossref

  50. Movassaghian Sara, Torchilin Vladimir P., Long-Circulating Therapies for Cancer Treatment, in Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies, 2015. Crossref

  51. Sercombe Lisa, Veerati Tejaswi, Moheimani Fatemeh, Wu Sherry Y., Sood Anil K., Hua Susan, Advances and Challenges of Liposome Assisted Drug Delivery, Frontiers in Pharmacology, 6, 2015. Crossref

  52. Vonarbourg Arnaud, Passirani Catherine, Desigaux Léa, Allard Emilie, Saulnier Patrick, Lambert Olivier, Benoit Jean-Pierre, Pitard Bruno, The encapsulation of DNA molecules within biomimetic lipid nanocapsules, Biomaterials, 30, 18, 2009. Crossref

  53. Rehberg Markus, Nekolla Katharina, Sellner Sabine, Praetner Marc, Mildner Karina, Zeuschner Dagmar, Krombach Fritz, Intercellular Transport of Nanomaterials is Mediated by Membrane Nanotubes In Vivo, Small, 12, 14, 2016. Crossref

  54. Klapperich Catherine, Kaufman Jessica, Wong Joyce, Controlling and Assessing Cell–Biomaterial Interactions at the Micro- and Nanoscale, in Biomaterials, 2007. Crossref

  55. Chen J., Zhang X.D., Nanodelivery of Anticancer Agents in Melanoma, in Nanoscience in Dermatology, 2016. Crossref

  56. Mrsny Randall, Active Targeting Strategies in Cancer with a Focus on Potential Nanotechnology Applications, in Nanotechnology for Cancer Therapy, 2006. Crossref

  57. Jiang Yuhang, Arounleut Phonepasong, Rheiner Steven, Bae Younsoo, Kabanov Alexander V., Milligan Carol, Manickam Devika S., SOD1 nanozyme with reduced toxicity and MPS accumulation, Journal of Controlled Release, 231, 2016. Crossref

  58. Polyak Boris, Friedman Gary, Magnetic targeting for site-specific drug delivery: applications and clinical potential, Expert Opinion on Drug Delivery, 6, 1, 2009. Crossref

  59. Cinti Caterina, Taranta Monia, Naldi Ilaria, Grimaldi Settimio, Ellis Steven, Newly Engineered Magnetic Erythrocytes for Sustained and Targeted Delivery of Anti-Cancer Therapeutic Compounds, PLoS ONE, 6, 2, 2011. Crossref

  60. Tabasum Shazia, Noreen Aqdas, Kanwal Arooj, Zuber Mohammad, Anjum Muhammad Naveed, Zia Khalid Mahmood, Glycoproteins functionalized natural and synthetic polymers for prospective biomedical applications: A review, International Journal of Biological Macromolecules, 98, 2017. Crossref

  61. McNeil Scott E., Nanotechnology for the biologist, Journal of Leukocyte Biology, 78, 3, 2005. Crossref

  62. Hughes Gareth A., Chapter 2: Nanostructure‒Mediated Drug Delivery, in Nanomedicine in Cancer, 2017. Crossref

  63. Zubair Swaleha, Azhar Asim, Khan Nazoora, Ahmad Ejaj, Ajmal Mohd, Owais Mohammad, Nanoparticle-Based Mycosis Vaccine, in Vaccines for Invasive Fungal Infections, 1625, 2017. Crossref

  64. Rahmanian Nazanin, Eskandani Morteza, Barar Jaleh, Omidi Yadollah, Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines, Journal of Drug Targeting, 25, 3, 2017. Crossref

  65. Zanganeh S., Ho J.Q., Aieneravaie M., Erfanzadeh M., Pauliah M., Spitler R., Drug Delivery, in Iron Oxide Nanoparticles for Biomedical Applications, 2018. Crossref

  66. Beduneau Arnaud, Ma Zhiya, Grotepas Cassi B., Kabanov Alexander, Rabinow Barrett E., Gong Nan, Mosley R. Lee, Dou Huanyu, Boska Michael D., Gendelman Howard E., Khoury Joseph El, Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles, PLoS ONE, 4, 2, 2009. Crossref

  67. Riaz Muhammad Kashif, Tyagi Deependra, Yang Zhijun, Surface Engineering: Incorporation of Bioactive Compound, in Bioactivity of Engineered Nanoparticles, 2017. Crossref

  68. Pedata Paola, Petrarca Claudia, Garzillo Elpidio Maria, Di Gioacchino Mario, Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles, International Journal of Immunopathology and Pharmacology, 29, 3, 2016. Crossref

  69. Hua Susan, de Matos Maria B. C., Metselaar Josbert M., Storm Gert, Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization, Frontiers in Pharmacology, 9, 2018. Crossref

  70. Wang Dongdong, Shi Ruohong, Zhou Jiajia, Shi Sixiang, Wu Huihui, Xu Pengping, Wang Hui, Xia Guoliang, Barnhart Todd E., Cai Weibo, Guo Zhen, Chen Qianwang, Photo-Enhanced Singlet Oxygen Generation of Prussian Blue-Based Nanocatalyst for Augmented Photodynamic Therapy, iScience, 9, 2018. Crossref

  71. Pashirova T. N., Burilova E. A., Lukashenko S. S., Lenina O. A., Zobov V. V., Khamatgalimov A. R., Kovalenko V. I., Zakharova L. Ya., Sinyashin O. G., Synthesis, Self-Association, and Solubilizing Ability of an Amphiphilic Derivative of Poly(ethylene glycol) Methyl Ether, Russian Journal of General Chemistry, 87, 12, 2017. Crossref

  72. Selvam Rajakar, Ramasamy Sivaraj, Mohiyuddin Shanid, Enoch Israel V.M.V., Gopinath Packirisamy, Filimonov Dmitry, Molecular encapsulator–appended poly(vinyl alcohol) shroud on ferrite nanoparticles. Augmented cancer–drug loading and anticancer property, Materials Science and Engineering: C, 93, 2018. Crossref

  73. Tsatsakis A., Stratidakis A.K., Goryachaya A.V., Tzatzarakis M.N., Stivaktakis P.D., Docea A.O., Berdiaki Ai, Nikitovic D., Velonia K., Shtilman M.I., Rizos A.K., Kuskov A.N., In vitro blood compatibility and in vitro cytotoxicity of amphiphilic poly-N-vinylpyrrolidone nanoparticles, Food and Chemical Toxicology, 127, 2019. Crossref

  74. Nordling-David Mirjam M, Rachamin Elior, Grad Etty, Golomb Gershon, Lysozyme transport to the brain by liposomes, Precision Nanomedicine, 1, 2, 2018. Crossref

  75. Srivastav Anurag Kumar, Dhiman Nitesh, Khan Hafizurrahman, Srivastav Ankur Kumar, Yadav Sanjeev Kumar, Prakash Jyoti, Arjaria Nidhi, Singh Dhirendra, Yadav Sanjay, Patnaik Satyakam, Kumar Mahadeo, Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System, Journal of Pharmaceutical Sciences, 108, 5, 2019. Crossref

  76. Gelperina Svetlana, Nanocarriers and Drug Delivery, in Regional Cancer Therapy, 2007. Crossref

  77. Chen Jiezhong, Zhao Kong-Nan, Vitetta Luis, Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways, Nutrients, 11, 5, 2019. Crossref

  78. Torchilin Vladimir, PEGylated Pharmaceutical Nanocarriers, in Long Acting Injections and Implants, 2012. Crossref

  79. Bae You Han, Park Kinam, Advanced drug delivery 2020 and beyond: Perspectives on the future, Advanced Drug Delivery Reviews, 158, 2020. Crossref

  80. Valic Michael S., Halim Michael, Schimmer Pamela, Zheng Gang, Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models, Journal of Controlled Release, 323, 2020. Crossref

  81. Li Qianyan, Hou Wei, Li Meixuan, Ye Hemin, Li Huanan, Wang Zhibiao, <p>Ultrasound Combined with Core Cross-Linked Nanosystem for Enhancing Penetration of Doxorubicin Prodrug/Beta-Lapachone into Tumors</p>, International Journal of Nanomedicine, Volume 15, 2020. Crossref

  82. Mi Peng, Miyata Kanjiro, Kataoka Kazunori, Cabral Horacio, Clinical Translation of Self‐Assembled Cancer Nanomedicines, Advanced Therapeutics, 4, 1, 2021. Crossref

  83. Feng Xingye, Gao Xiaoling, Kang Ting, Jiang Di, Yao Jianhui, Jing Yixian, Song Qingxiang, Jiang Xinguo, Liang Jianying, Chen Jun, Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG–PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy, Bioconjugate Chemistry, 26, 8, 2015. Crossref

  84. Borm Paul JA, Müller-Schulte Detlef, Nanoparticles in drug delivery and environmental exposure: same size, same risks?, Nanomedicine, 1, 2, 2006. Crossref

  85. Moghimi S.M., Hunter A.C., Andresen T.L., Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective, Annual Review of Pharmacology and Toxicology, 52, 1, 2012. Crossref

  86. Lu Lina, Kang Shuhe, Sun Chao, Sun Chufeng, Guo Zhong, Li Jia, Zhang Taofeng, Luo Xingping, Liu Bin, Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers, Current Topics in Medicinal Chemistry, 20, 27, 2020. Crossref

  87. Meng Xiangjun, Zhang Zhi, Tong Jin, Sun Hui, Fawcett John Paul, Gu Jingkai, The biological fate of the polymer nanocarrier material monomethoxy poly(ethylene glycol)-block-poly(d,l-lactic acid) in rat, Acta Pharmaceutica Sinica B, 11, 4, 2021. Crossref

  88. Feng Xingye, Yao Jianhui, Gao Xiaoling, Jing Yixian, Kang Ting, Jiang Di, Jiang Tianze, Feng Jingxian, Zhu Qianqian, Jiang Xinguo, Chen Jun, Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy, ACS Applied Materials & Interfaces, 7, 50, 2015. Crossref

  89. Huda Md Nurul, Nafiujjaman Md, Deaguero Isaac G., Okonkwo Jude, Hill Meghan L., Kim Taeho, Nurunnabi Md, Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications, ACS Biomaterials Science & Engineering, 7, 6, 2021. Crossref

  90. Griffin James I., Wang Guankui, Smith Weston J., Vu Vivian P., Scheinman Robert, Stitch Dominik, Moldovan Radu, Moghimi Seyed Moein, Simberg Dmitri, Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy, ACS Nano, 11, 11, 2017. Crossref

  91. Li Huanan, Ma Ming, Zhang Jingni, Hou Wei, Chen Hangrong, Zeng Deping, Wang Zhibiao, Ultrasound-Enhanced Delivery of Doxorubicin-Loaded Nanodiamonds from Pullulan-all-trans-Retinal Nanoparticles for Effective Cancer Therapy, ACS Applied Materials & Interfaces, 11, 22, 2019. Crossref

  92. Danz Karin, von Briesen Hagen, Wagner Sylvia, Biodegradable Nanoparticles for Specific Drug Transport, in New Trends in Macromolecular and Supramolecular Chemistry for Biological Applications, 2021. Crossref

  93. Zahr Alisar S., Davis Cheryl A., Pishko Michael V., Macrophage Uptake of Core−Shell Nanoparticles Surface Modified with Poly(ethylene glycol), Langmuir, 22, 19, 2006. Crossref

  94. Céspedes María Virtudes, Unzueta Ugutz, Tatkiewicz Witold, Sánchez-Chardi Alejandro, Conchillo-Solé Oscar, Álamo Patricia, Xu Zhikun, Casanova Isolda, Corchero José Luis, Pesarrodona Mireia, Cedano Juan, Daura Xavier, Ratera Imma, Veciana Jaume, Ferrer-Miralles Neus, Vazquez Esther, Villaverde Antonio, Mangues Ramón, In VivoArchitectonic Stability of Fullyde NovoDesigned Protein-Only Nanoparticles, ACS Nano, 8, 5, 2014. Crossref

  95. Aizik Gil, Waiskopf Nir, Agbaria Majd, Ben-David-Naim Meital, Levi-Kalisman Yael, Shahar Amit, Banin Uri, Golomb Gershon, Liposomes of Quantum Dots Configured for Passive and Active Delivery to Tumor Tissue, Nano Letters, 19, 9, 2019. Crossref

  96. Mortimer Gysell M., Butcher Neville J., Musumeci Anthony W., Deng Zhou J., Martin Darren J., Minchin Rodney F., Cryptic Epitopes of Albumin Determine Mononuclear Phagocyte System Clearance of Nanomaterials, ACS Nano, 8, 4, 2014. Crossref

  97. Zahr Alisar S., Pishko Michael V., Encapsulation of Paclitaxel in Macromolecular Nanoshells, Biomacromolecules, 8, 6, 2007. Crossref

  98. BarathManiKanth Selvaraj, Kalishwaralal Kalimuthu, Sriram Muthuirulappan, Pandian SureshBabu Ram Kumar, Youn Hyung-seop, Eom SooHyun, Gurunathan Sangiliyandi, Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice, Journal of Nanobiotechnology, 8, 1, 2010. Crossref

  99. Barnes Jonathan C., Bruno Peter M., Nguyen Hung V.-T., Liao Longyan, Liu Jenny, Hemann Michael T., Johnson Jeremiah A., Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity, Journal of the American Chemical Society, 138, 38, 2016. Crossref

  100. Cheng Xiaobo, Wang Chunling, Su Yuqing, Luo Xiang, Liu Xinrong, Song Yanzhi, Deng Yihui, Enhanced Opsonization-Independent Phagocytosis and High Response Ability to Opsonized Antigen–Antibody Complexes: A New Role of Kupffer Cells in the Accelerated Blood Clearance Phenomenon upon Repeated Injection of PEGylated Emulsions, Molecular Pharmaceutics, 15, 9, 2018. Crossref

  101. Himiniuc Loredana Maria, Toma Bogdan Florin, Popovici Razvan, Grigore Ana Maria, Hamod Alexandru, Volovat Constantin, Volovat Simona, Nica Irina, Vasincu Decebal, Agop Maricel, Tirnovanu Mihaela, Ochiuz Lacramioara, Negura Anca, Grigore Mihaela, Ortega Enrique, Update on the Use of Nanocarriers and Drug Delivery Systems and Future Directions in Cervical Cancer, Journal of Immunology Research, 2022, 2022. Crossref

  102. Ferguson Laura T., Hood Elizabeth D., Shuvaeva Tea, Shuvaev Vladimir V., Basil Maria C., Wang Zhicheng, Nong Jia, Ma Xiaonan, Wu Jichuan, Myerson Jacob W., Marcos-Contreras Oscar A., Katzen Jeremy, Carl Justine M., Morrisey Edward E., Cantu Edward, Villa Carlos H., Mitragotri Samir, Muzykantov Vladimir R., Brenner Jacob S., Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers, ACS Nano, 16, 3, 2022. Crossref

  103. Dobrovolskaia Marina A., McNeil Scott E., Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines, Journal of Controlled Release, 172, 2, 2013. Crossref

  104. Liu Xinying, Ge Weidong, The Emerging Role of Ultrasonic Nanotechnology for Diagnosing and Treatment of Diseases, Frontiers in Medicine, 9, 2022. Crossref

  105. Tao Zhang, Kuai Xingwang, Wang Guangwei, Liu Sanfeng, Liu Kai, Zhang Heng, Xia Shujing, Zhu Hua, Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC, Drug Delivery, 29, 1, 2022. Crossref

  106. Hassan Atef A., Sayed-ElAhl Rasha M.H., El-Hamaky Ahmed M.A., Mansour Mogda K., Oraby Noha H., Copper nanoparticles: Synthesis, characterization, and its veterinary applications, in Copper Nanostructures: Next-Generation of Agrochemicals for Sustainable Agroecosystems, 2022. Crossref

  107. Praphawatvet Tuangrat, Peters Jay I., Williams Robert O., Inhaled nanoparticles–An updated review, International Journal of Pharmaceutics, 587, 2020. Crossref

  108. Ren Tianming, Li Runzhi, Zhao Liqiang, Fawcett J. Paul, Sun Dong, Gu Jingkai, Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate, Acta Pharmaceutica Sinica B, 12, 7, 2022. Crossref

  109. Jin Yuanyuan, Wang Haixia, Yi Ke, Lv Shixian, Hu Hanze, Li Mingqiang, Tao Yu, Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure, Nano-Micro Letters, 13, 1, 2021. Crossref

  110. Haroon H.B., Hunter A.C., Farhangrazi Z.S., Moghimi S.M., A brief history of long circulating nanoparticles, Advanced Drug Delivery Reviews, 188, 2022. Crossref

  111. Dobrovolskaia Marina A., Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory, Frontiers in Immunology, 13, 2022. Crossref

  112. Moghimi S. Moein, Haroon Hajira B., Yaghmur Anan, Simberg Dmitri, Trohopoulos Panagiotis N., Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles, Journal of Controlled Release, 351, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain